Post Profile

Blood tests at the time of diagnoses of lung cancer may speed up treatment decisions

(American College of Chest Physicians) A study from Gundersen Health System, La Crosse, Wisconsin, reveals to the value of blood-based genomic and proteomic testing in patients with lung cancer at the time of initial diagnoses. In this study, genomic and proteomic testing of blood specimens rapidly identified genetic mutations that determined optimal, personalized treatment.
read more


Related Posts

Pathway Genomics Responds To Medco, Mayo Clinic Study Revealing Gene Testing Reduces Hospitalization Rates For Warfarin Patients

Health : Medical News Today

Pathway Genomics Inc., a U.S. based genetic testing company, responded to research released at the American College of Cardiology annual meeting that found that the number of hospitalizations for heart patients taking warfarin, the ...

Leading Respiratory Health Societies Welcome Preliminary Decision on Lung Cancer Screening for Eligible Medicare Recipients

Health : Newswise Medical News

The American Thoracic Society (ATS) and the American College of Chest Physicians (CHEST) welcome today's preliminary decision by the Centers for Medicare & Medicaid Services (CMS) to cover lung cancer screening with low dose compute...

Scientists Develop Personalized Blood Tests for Cancer Using Whole Genome Sequencing

Health : Newswise Medical News

Scientists at the Johns Hopkins Kimmel Cancer Center have used data from the whole genome sequencing of cancer patients to develop individualized blood tests they believe can help physicians tailor patients' treatments. The genome-b...

Study Indicates Breast Cancer Diagnosis Is More Accurate with New Genomic Tests

Health : Newswise Medical News

The latest generation of genomic tests for breast cancer can improve physicians' ability to diagnose the disease and more precisely tailor each patient's treatment, according to a study being presented at the 2012 CTRC-AACR San Anto...

Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients with Targeted Therapies Transforms Care

Health : Newswise Medical News

New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients with the most common type of lung cancer has helped transform treatment for the disease.


Copyright © 2016 Regator, LLC